Lack of association between the Paraoxonase 1 Q/R192 single nucleotide polymorphism and stroke in a Chinese cohort

Acta Neurologica Belgica

Volumn 109, Issue 3, 2009, Pages 205-209

  Xiao, Z J ^a   Chen, J ^b   Sun, Y ^a   Zheng, Z J ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Cerebral hemorrhage; Ischemic stroke; Paraoxonase 1; Polymorphism; Stroke

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ADULT; AGED; ALLELE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AGED; ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 70350500428     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Allebrandt KV, Souza RL, Chautard-Freire-Maia EA. Variability of the paraoxonase gene (PON1) in Euro- and Afro-Brazilians. Toxicol Appl Pharmacol. 2002;180:151-156.
2. Aubó C, Sentí M, Marrugat J, Tomas M, Vila J. et al. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators. Eur Heart J. 2000;21:33-38
3. Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Nacak M, Tapanyigit EE. et al. Paraoxonase 1 mutations in a Turkish population. Toxicol Appl Pharmacol. 1999; 157: 174-177.
4. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J. et al. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol. 1999;19(2):330-335
5. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X. et al. Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk. JAMA. 2008;299(11):1265-1276.
6. Can Demirdöǧen B, Türkanoǧlu A, Bek S, Sanisoǧlu Y, Demirkaya S. et al. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Clin Biochem. 2008;41(1-2):1-9.
7. Chai J, Chu FC, Chow TW, Shum NC. Prevalence of malnutrition and its risk factors in stroke patients residing in an infirmary. Singapore Med J. 2008; 49(4):290-296 (Pubitemid 351716735)
8. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21(4):473-480.
9. Graff-Iversen S, Jenum AK, Grøtvedt L, Bakken B, Selmer RM, et al. Risk factors for myocardial infarction, stroke and diabetes in Norway. Tidsskr Nor Laegeforen. 2007;127(19):2537-2541
10. Hegele RA. Paraoxonase genes and disease. Ann Med. 1999;31(3):217-224.
11. Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N. et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic disease. Atherosclerosis. 2000;149:435-442. (Pubitemid 30145555)
12. Komori T, Eguchi K, Tomizawa H, Ishikawa J, Hoshide S. et al. Factors associated with incident ischemic stroke in hospitalized heart failure patients: a pilot study. Hypertens Res. 2008;31(2):289-294
13. Li HL, Liu DP, Liang CC. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med. 2003;81(12):766-779.
14. Mackness B, Durrington P, McElduff P, Yarnell J, Azam N. et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation. 2003;107(22):2775-2779 (Pubitemid 36705985)
15. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K. et al. Serum paraoxonase 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis. 1998;139(2):341-349 (Pubitemid 28361819)
16. Mackness M, Mackness B. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? Free Radic Biol Med. 2004;37(9):1317-1323.
17. Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ. et al. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest. 1997; 99(8):2005-2019 (Pubitemid 27175949)
18. Oda MN, Bielicki JK, Ho TT, Berger T, Rubin EM. et al. Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins. Biochim Biophys Res Commun. 2002; 290:921-927. (Pubitemid 34687449)
19. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 1996;33(3):498-507. (Pubitemid 26159866)
20. Rozenberg O, Rosenblat M, Coleman R, Shih DM. et al. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med. 2003;34(6):774-784. (Pubitemid 36288542)
21. Schiavon R, Turazzini M, De Fanti E, Battaglia P, Targa L. et al. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals. Acta Neurol Scand. 2007;116(1):26-30. (Pubitemid 46976264)
22. Shin BS, Oh SY, Kim YS, Kim KW. The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand. 2008;117(4):237-243
23. Shih DM, Gu L, Xia YR, Navab M, Li WF. et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 1998;394(6690):284-287. (Pubitemid 28335041)
24. Shih DM, Xia YR, Wang XP, Miller E, Castellani LW et al. Combined serum paraoxonase knockout/ apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem. 2000;275(23):17527-17535 (Pubitemid 30430794)
25. Topić, E, Simundić AM, Ttefanović M, Demarin V, Vuković V. et al. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate (MTHFR) and poraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med. 2001;39:346-350. (Pubitemid 32433336)
26. Turban S, Fuentes F, Ferlic L, Brugada R, Gotto AM. et al. A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin. Atherosclerosis. 2001;154:633-640
27. Tward A, Xia YR, Wang XP, Shi YS, Park C. et al. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation. 2002;106(4):484-490. (Pubitemid 34803695)
28. Voetsch B, Benke KS, Damasceno BP, Siqueira LH, Loscalzo J. Paraoxonase 192 Gln -> Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke. 2002;33(6):1459-1464 (Pubitemid 34619940)
29. Yamada M, Sodeyama N, Itoh Y, Otomo E, Matsushita M. et al. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke. 2002;33(4):896-900. (Pubitemid 34293564)
30. Zuliani G, Cherubini A, Volpato S, Palmieri E, Mecocci P. et al. Genetic factors associated with the absence of atherosclerosis in octogenarians. J Gerontol A Biol Sci Med Sci. 2002;57:M611-5. (Pubitemid 34977770)